当前位置：
X-MOL 学术
›
Cancer Treat. Rev.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin's lymphoma.
Cancer Treatment Reviews ( IF 11.8 ) Pub Date : 2003-10-31 , DOI: 10.1016/j.ctrv.2003.09.002 Donna E Reece 1 , Anna Sureda
中文翻译：
高剂量疗法和自体干细胞移植与晚期霍奇金淋巴瘤的初始治疗后有较高复发风险的人群相比，继续进行联合化疗不能提高生存率。
更新日期：2019-11-01
Cancer Treatment Reviews ( IF 11.8 ) Pub Date : 2003-10-31 , DOI: 10.1016/j.ctrv.2003.09.002 Donna E Reece 1 , Anna Sureda
Affiliation
中文翻译：
高剂量疗法和自体干细胞移植与晚期霍奇金淋巴瘤的初始治疗后有较高复发风险的人群相比，继续进行联合化疗不能提高生存率。
京公网安备 11010802027423号